Value of ultrasound-guided fine needle aspiration cytology in the assessment of ovarian neoplasms and retroperitoneal metastatic lymph nodes
10.3877/cma.j.issn.1672-6448.2017.10.015
- VernacularTitle:超声引导细针穿刺细胞病理学对卵巢肿瘤及腹膜后转移性淋巴结的临床诊断价值
- Author:
Junping LIU
1
,
2
;
Weimin MAO
;
Dong XU
;
Haimiao XU
;
Ye CHENG
;
Hanmei LOU
;
Liyu CHEN
;
Min LYU
;
Fang CHENG
Author Information
1. 310022 杭州,浙江省肿瘤医院介入超声科
2. 浙江省胸部肿瘤(食管、肺)诊治技术研究重点实验室
- Keywords:
Retroperitoneal lymph nodes;
Ovarian oncology;
Ultrasound;
Fine needle aspiration cytology;
Clinical value
- From:
Chinese Journal of Medical Ultrasound (Electronic Edition)
2017;14(10):794-798
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the diagnostic value of ultrasound-guided fine needle aspiration cytology(US-FNAC)in the assessment of radiologically detected ovarian neoplasms and retroperitoneal metastatic lymph nodes. Methods FNAC was performed under ultrasound guidance on 126 patients suspected of ovarian neoplasms and retroperitoneal metastatic lymph nodes. Cytologic examination was performed after staining smears with the haematoxylin and eosin method. Clinical data were retrieved from the medical records and all cytological specimens were reviewed. In these cases, the cytologic findings were correlated with histology of the primary tumor and were compared with surgical pathology. Results Satisfactory sampling was obtained in 86.2% of punctures, and cytological diagnosis was made in 85.7% cases. The size of the lymph nodes punctured was less than 20 mm in 93.5% cases, with the sensitivity of 81.6%、86.2%, specificity of 95.8%、100.0%, positive predictive value of 98.3%、100.0%, negative predictive value of 63.9%、33.3%, and accuracy of 85.3%、87.1%. Seven patients presented slight abdominal discomfort, and relieved without clinical treatment. Conclusions The fine needle aspiration technique has excellent positive predictive value and low morbidity. US-FNAC, as the valuable investigation, is not only useful in the diagnosis of ovarian masses and lymph nodes but can also help in choosing appropriate management. From our experience, US-FNAC can be added in follow-up of selected patients in whom the cytological identification of such masses and nodes is significant for the patient′s treatment.
